Skip to content
PatentBrief
Get alertsTop ↑

Marking Heart Valve Commissures for Better Imaging

This patent describes a method for attaching a special marker to a prosthetic heart valve that shows up on X-rays, helping doctors see the exact position of the valve's leaflets during surgery.

Granted 2026ActiveExpires 2044

Original patent title: “Commissure marker for a prosthetic heart valve”

Plain-English explanation by SahiLast reviewed · October 8, 2026

This patent describes a method for attaching a special marker to a prosthetic heart valve that shows up on X-rays, helping doctors see the exact position of the valve's leaflets during surgery. Granted in 2026.

Coverage

What does this patent actually cover?

This patent describes a way to add a special marker to a prosthetic heart valve, based on its abstractabstractA short summary at the front of the patent describing the invention. Not legally binding.Read more →. The marker is "radiopaque," meaning it shows up clearly on X-rays or other medical scans. Specifically, the patent details attaching this marker to an "attachment member" that forms part of a "commissure" — the point where two valve leaflets meet. The marker is placed on a "flap" of this attachment member, hidden between the flap and the central part of the attachment. This helps doctors see the exact orientation of the valve's commissures during implantation procedures.

The gap

What does this patent NOT cover?

  • Does not cover markers that are not radiopaque, such as those visible only with ultrasound or MRI.
  • Does not cover markers placed directly on the valve leaflets or frame, rather than on the commissure's attachment member.
  • Does not cover markers that are not hidden between a flap and a central portion of an attachment member.
  • Does not cover methods of marking commissures that do not involve a folded flap structure.
  • Does not cover markers that are not specifically used to indicate the location of a commissure.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12734031
StatusActive
FieldBiotech & Medicine
Filed2024
Granted2026
Times cited0
LitigationNone on record
Value · $26K–$84KMinimal

What made this novel

The noveltynoveltyThe requirement that an invention be different from anything publicly known before its priority date.Read more → lies in the specific, hidden placement of the radiopaque marker within the commissure's attachment structure. By tucking it between a folded flap and a central portion, the marker can indicate the commissure's position without interfering with valve function or being easily dislodged.

Commissure marker for a prosth…(Primary claim)medical devicesbiotechhealthcare

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Transcatheter aortic valve replacement (TAVR) devices

02

Surgical heart valves

03

Implantable medical devices requiring precise orientation

Why it matters

The bigger picture

Accurate placement of prosthetic heart valves is crucial for patient outcomes. This marker helps surgeons precisely orient the valve during procedures like transcatheter aortic valve replacement (TAVR). By clearly showing the commissure locations on imaging, it reduces the risk of misalignment, which can lead to complications or reduced valve function.

Filed

January 24, 2024

Granted

September 15, 2026

Market context

Who's building on this

Companies in this space

Companies like Medtronic, Edwards Lifesciences, and Abbott Laboratories are major players in the prosthetic heart valve market. These companies continuously innovate in valve design and implantation techniques, including improving visibility and guidance for surgeons during procedures.

Market impact

This type of innovation aims to improve the safety and efficacy of heart valve replacement procedures, particularly minimally invasive ones. Better visualization tools can lead to faster procedures, fewer complications, and improved long-term outcomes for patients, driving adoption of advanced valve technologies.

Claim 1 — Plain English

What this patent covers

This patent describes a way to add a special marker to a prosthetic heart valve, based on its abstract. The marker is "radiopaque," meaning it shows up clearly on X-rays or other medical scans. Specifically, the patent details attaching this marker to an "attachment member" that forms part of a "commissure" — the point where two valve leaflets meet. The marker is placed on a "flap" of this attachment member, hidden between the flap and the central part of the attachment. This helps doctors see the exact orientation of the valve's commissures during implantation procedures.

The clever bit

The novelty lies in the specific, hidden placement of the radiopaque marker within the commissure's attachment structure. By tucking it between a folded flap and a central portion, the marker can indicate the commissure's position without interfering with valve function or being easily dislodged.

What it does not cover

  • Does not cover markers that are not radiopaque, such as those visible only with ultrasound or MRI.
  • Does not cover markers placed directly on the valve leaflets or frame, rather than on the commissure's attachment member.
  • Does not cover markers that are not hidden between a flap and a central portion of an attachment member.
  • Does not cover methods of marking commissures that do not involve a folded flap structure.
  • Does not cover markers that are not specifically used to indicate the location of a commissure.

Patent timeline

Filing

Application submitted to the patent office

Grant

Patent officially issued

PatentBrief Score

Impact Score

Early stage

Citation count

0/40

No citations yet

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$26K – $84K

Midpoint $53K · 17.3 yr remaining · industry ×2.2

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Cite this patent

(2026). Marking Heart Valve Commissures for Better Imaging (U.S. Patent No. 12,734,031). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12734031/commissure-marker-for-a-prosthetic-heart-valve

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12734031"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:medical devices patents →biotech patents →healthcare patents →

Common Questions

Frequently Asked Questions

What does Marking Heart Valve Commissures for Better Imaging cover?

This patent describes a method for attaching a special marker to a prosthetic heart valve that shows up on X-rays, helping doctors see the exact position of the valve's leaflets during surgery.

When does this patent expire?

This patent is expected to expire on September 15, 2046, when the invention enters the public domain.

What problem does this patent solve?

Accurate placement of prosthetic heart valves is crucial for patient outcomes. This marker helps surgeons precisely orient the valve during procedures like transcatheter aortic valve replacement (TAVR). By clearly showing the commissure locations on imaging, it reduces the risk of misalignment, which can lead to complications or reduced valve function.

What does this patent NOT cover?

Does not cover markers that are not radiopaque, such as those visible only with ultrasound or MRI.

Patent monitoring

Get notified when new matching patents are published

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: October 8, 2026 · PatentBrief is not a law firm and this is not legal advice.